New diabetes drug HR17031 could beat standard insulin in blood sugar control
NCT ID NCT06881264
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tested whether a new injectable drug, HR17031, works better than standard insulin glargine for controlling blood sugar in Chinese adults with type 2 diabetes. The study included 401 people whose diabetes was not well controlled with oral medications. Researchers measured changes in HbA1c (a blood sugar marker) and body weight over 26 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HR17031 injection
- What this could lead to
- If it works, HR17031 could offer better blood sugar control with less weight gain than standard insulin glargine for people with type 2 diabetes.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. HR17031 may not prove superior or could have unexpected side effects. The study only included Chinese participants, so findings may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON ORAL ANTIDIABETIC DRUGS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
- Could a common diabetes drug weaken your bones?
- Can a spice and a mindset shift ease diabetic nerve pain?
- Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
- Could a peptide injection help rebuild Insulin-Making cells?
- A pill for diabetes? new oral drug aims to rival injections